万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://journals.lww.com/dcrjournal/pages/default.aspx
3、投稿网址：
https://app.penelope.ai/manuscript-check/q/dcr
或：https://www.editorialmanager.com/dcr/
4、官网邮箱：dcrjournalmanagingeditor@gmail.com
tarisashton@gmail.com
更多邮箱如下投稿须知内信息。
5、期刊刊期：月刊，一年出版12期。
2021年8月9日星期一
投稿须知【官网信息】
Instructions for Authors
SCOPE
Diseases of the Colon & Rectum is the Journal of The American Society of Colon and Rectal Surgeons. The mission of the Journal is to advance knowledge of disorders of the small intestine, colon, rectum, and anus. It publishes original articles, review papers, editorials, practice parameters, and letters to the editor. Major areas of interest include colorectal and anal cancer, inflammatory bowel disease, benign colonic conditions, anorectal disorders, and pelvic floor disorders. The Journal's main focus is on surgical issues, though other material directly related to these topics is also published. All submitted material is subject to a peer-review process.
SUBMISSION CHECKLIST
Cover Letter
1. State that all authors have read and complied with author guidelines
2. State that you are submitting a manuscript for peer review, the title and type of manuscript, and the authors
3. Briefly describe the contribution to the field and suitability for DCR
4. Provide any additional relevant information to the editor. For example, if you have submitted or published a manuscript(s) on a similar topic that might be regarded as redundant or duplicative, highlight how the current submission differs from that work in order to avoid any appearance of duplicate publishing. All prior relevant publications should be referred to specifically, in the cover letter and also referenced in the new paper.
5. The work must be original and neither published, accepted, or submitted elsewhere. Authors should be aware that DCR is committed to following the highest standards of publication ethics as promoted by the Committee on Publication Ethics (COPE, https://publicationethics.org/).
Title Page(s)
1. Title
2. Short running head ≤ 40 characters (count letters and spaces)
3. First name, middle initial, last name, highest academic degree, academic title, and institution/department for each author. IF THE NUMBER OF AUTHORS IN YOUR MANUSCRIPT EXCEEDS 8 AUTHORS, authorship credit should be based on substantial contributions to conception and design; acquisition of data, analysis and interpretation of data; drafting the article or revising it critically for important intellectual content; and final approval of the version to be published. Authors MUST meet all of these conditions. We are happy to acknowledge contributors who do not fulfill authorship criteria at the end of the paper. Our policy is based upon the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” statement of the International Committee of Medical Journal Editors at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html. If there are more than 8 authors, please follow the additional steps listed below.
Step 1: Please complete and sign the DCR Authorship Contribution Form available at https://tinyurl.com/ybj5pgdq. Each author must check at least one box in each of the 4 authorship categories. Potential authors who do not fulfill the criteria of at least one box checked in each of the 4 categories should be listed in the “Acknowledgments.”
Step 2: Please upload the completed and signed DCR Authorship Contribution Form with your DCR submission in Editorial Manager.
4. Name, address, telephone, fax, current e-mail address, and Twitter account(if available) of author responsible for correspondence about the manuscript
5. Disclaimers, for example, conflicts of interest, use of off-label or unapproved drugs or products, use of previously copyrighted material
6. Source(s) of support (i.e. grants, equipment, drugs) or state if there is no funding. Authors should list any relevant financial relationships (see Disclosure Statement in Editorial Manager) or state explicitly that there are none
NOTE, IF THERE IS NO GRANT SUPPORT OR FINANCIAL RELATIONSHIP, THERE MUST BE A STATEMENT STATING THIS ON THE TITLE PAGE
7. State if manuscript has been or will be a podium or poster meeting presentation and provide the name of the meeting, location (city, state and country if not U.S.), and include start AND end dates of the ENTIRE meeting
8. PROVIDE WORD COUNT. The word count for the text (3000-word limit) and abstract (300-word limit) must be on the title page.
Abstract
1. Abstract word count ≤300
No abbreviations are allowed in the abstract.
2. Structured abstract
Original & Dynamic articles:
Current Status Review, systematic reviews, meta-analyses:
Background, Objective, Design, Settings, Patients, Interventions(s) if any, Main Outcome Measures, Results, Limitations, Conclusions.
Background, Objective, Data Sources, Study Selection, Intervention(s), Main Outcome Measures, Results, Limitations, Conclusions
STRUCTURED ABSTRACT (300-word limit):
BE SURE TO USE THESE SPECIFIC HEADERS WHEN FORMATTING AND SUBMITTING THE ABSTRACT WITH YOUR PAPER. If not done, the paper will be returned to authors for compliance prior to any review process.
3. VIDEO ABSTRACT STATEMENT PLEASE ADD THIS STATEMENT ON YOUR TITLE PAGE
IF the manuscript is provisionally accepted, a VIDEO ABSTRACT will be required prior to final acceptance.
Text
1. Arrange in order: Introduction; Materials & Methods; Results; Discussion and Conclusion; Acknowledgements.
2. Adhere to study guidelines (checklists) for type of study submitted.
http://www.equator-network.org/ and UPLOAD COMPLETED AND APPROPRIATE QUALITY REPORTING CHECKLIST.
Be sure to ATTACH the COMPLETED checklist file under “Checklist to Quality Reporting Guidelines” with your submission in Editorial Manager.
Please complete and BE SURE to provide the text page locations for each question. If not done, the paper will be returned to authors for compliance prior to any review process.
Authors of randomized controlled trials must adhere to the CONSORT guidelines, available at: http://www.consort-statement.org/ and provide both a CONSORT checklist and flow diagram.
Authors of CURRENT STATUS articles must adhere to the guidelines outlined in the PRISMA statement and provide both a PRISMA checklist and flow diagram. For the most up-to-date information about these guidelines and access to future revisions, visit http://www.prisma-statement.org. Please see PRISMA flow chart generator http://prisma.thetacollaborative.ca/
Randomized Controlled Trials
Systematic Reviews
Systematic Review and Meta-Analysis of Observational Studies
Observational Studies (e.g. retrospective reviews)
Quality Improvement Studies
Qualitative Research
Tumor Marker Prognostic Studies
Genetic Association Studies
Animal Pre-Clinical Studies
Systematic Reviews and Meta-Analysis of Genetic Association Studies
CONSORT
PRISMA
MOOSE
STROBE
SQUIRE
COREQ
REMARK
STREGA
ARRIVE
HuGEnET
3. References ≤ 40 except for Current Status Reviews, Technical Notes, and Video Vignettes
Citations in the text should be identified by superscript Arabic numerals without parentheses.
References at the end of paper numbered consecutively in the order they are mentioned in the text.
Tables
1. Create a SEPARATE file for each table for manuscript submission in Editorial Manager.
2. Tables must be numbered consecutively within manuscript with Arabic numerals. Footnotes to tables indicated by lowercase superscript letters.
Figures
1. Legend. Number figures in the figure legend in the order in which they are discussed.The figure legend should be brief, self-sufficient explanations of the figures and tables in no more than four or five lines.
Figure legends should follow the references and be typed double-spaced on a separate page
If symbols, arrows, numbers, or letters are used to identify parts of the illustration, identify and explain each one clearly,
2. Create a SEPARATE file for each figure or photo for manuscript submission in Editorial Manager.
3. Cite figures consecutively in your manuscript.
4. For publication requirements for Digital Artwork:
http://links.lww.com/ES/A42
Artwork should be saved as the actual size or larger than it will appear in DCR as TIFF, PDF, Word Doc, PPT, or EPS files.
• Diagrams, drawings, graphs, other line art should be vector or saved at ≥ 1200 dpi.
5. For details regarding photo and image resolution see:
http://edmgr.ovid.com/dcr/accounts/ifauth.htm#manpre1
• Photographs, radiographs, halftone images must be saved at ≥ 300 dpi
• Photographs, radiographs, halftone images with text must be saved at ≥ 600 dpi.
6. Five Steps for Creating Digital Artwork
http://edmgr.ovid.com/dcr/accounts/ifauth.htm
Required Forms
1. Copyright Transfer Statement Submitted through Editorial Manager
2. Disclosure Statement Submitted through Editorial Manager
FORMS REQUIRED WITH SUBMISSION:
Copyright Transfer Statement
Disclosure Statement
MANUSCRIPT SUBMISSION GUIDELINES
MANUSCRIPT PREPARATION GUIDELINES
FIGURES
CONSENSUS STATEMENTS
LEGAL REQUIREMENTS
FORMS REQUIRED WITH SUBMISSION
Copyright Transfer Statement:
Each author must complete the Journal's copyright transfer agreement. A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.
Disclosure Statement:
Conflicts of interest: Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”. For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.
Each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html).
A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.
Open access process
While the submission and review process follows the traditional process, there are additional forms and steps that need to be taken to publish your work as open access. If authors of accepted manuscripts wish to continue with OPEN ACCESS, you will need to complete a License to Publish (LTP) form and make a payment for the article through qconnect: http://wolterskluwer.qconnect.com. To complete an LTP form and make a payment for the article through qconnect, follow these steps:
Step 1: LTP (required). Wolters Kluwer's License to Publish (LTP) form must be completed, in full, by the corresponding author on behalf of all the authors before an article can be made OPEN ACCESS. This form may be uploaded with the manuscript, which routes it to the publisher for the first step in the paperwork. Go here for the form: https://download.lww.com/wolterskluwer_vitalstream_com/PermaLink/LWW-ES/A/LWW-ES_2017_03_27_LTP_1_SDC1.pdf
Step 2: Payment (required). Payment for OPEN ACCESS is the last step. First-time authors will have to create an account/log in. Please note: this account is separate from any other accounts you may have for the Journal. You will be asked for the following information. Please enter exactly as shown:
- Article Title - %ARTICLE_TITLE%
- Manuscript Number - %MS_NUMBER%
Additional instructions from Wolters Kluwer instructions: http://www.wkopenhealth.com/Process.html
MANUSCRIPT SUBMISSION GUIDELINES
NEW The Diseases of the Colon & Rectum is pleased to offer authors a free rapid manuscript checking tool. Penelope.ai is an online tool that automatically checks manuscripts. It helps authors double check that their work meets journal requirements before submitting. The tool is free, fast, and may help spot mistakes that could otherwise delay a submission. Link: https://app.penelope.ai/manuscript-check/q/dcr Manuscripts may also be submitted on-line through the web site at https://www.editorialmanager.com/dcr/.
First-time users: Please click the Register button from the menu above and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). NOTE: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in.
Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact tarisashton@gmail.com or dcrjournalmanagingeditor@gmail.com.
SYSTEM REQUIREMENTS
System requirements can be found at http://www.editorialmanager.com/homepage/faq.html#faq11
AUTHORSHIP
DCR uses the CRediT taxonomy to define author contributions and requires that the independent contributions of each author be provided during online submission. It is the responsibility of the corresponding author to ensure that contributions are agreed on by ALL co-authors prior to manuscript submission. DCR also requires that the corresponding author provide an ORCID ID at online submission. The registration process is quick and simple. Please go here to register if you do not have an ORCID ID https://orcid.org/. See video from Editor-in-Chief Susan Galandiuk on "Surnames and ORCID ID" at https://journals.lww.com/dcrjournal/pages/videogallery.aspx?videoId=45&autoPlay=true.
The Diseases of the Colon and Rectum considers group or collaborative authorship. Authors are asked to comply with the instructions below when considering such a submission. The corresponding author may choose one of the following options.
Option 1. The corresponding author may choose to list all members of the group collaborative to be authors. If this option is chosen, then all should meet the four criteria for authors and all must sign the copyright form. They will also be expected as individuals to complete conflict-of-interest disclosure forms.
Option 2. The corresponding author of a group collaborative submission has the option to specify lead "writing" authors who take public responsibility for the work and should have full confidence in the accuracy and integrity of the work on behalf of the collaborative. These lead authors are listed as authors on the title page of the manuscript. These authors must sign copyright forms and meet authorship criteria. The corresponding author must also specify on the title page the group name of the collaborative. The phrasing may be: "On behalf of ___ Collaborative." Members of the group collaborative who are not lead authors are to be listed by full name in alphabetic order in the Acknowledgment section of the manuscript. All names provided will then appear in PubMed as "Collaborators." See the example in the publication Dis Colon Rectum 2019;62:794-801.
Our policy regarding group authorship is based upon the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" statement of the International Committee of Medical Journal Editors at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html. ICMJE policy states: "When a large multi-author group has conducted the work, the group ideally should decide who will be an author before the work is started and confirm who is an author before submitting the manuscript for publication." This is in compliance with the ICMJE policy: "All members of the group named as authors should meet all four criteria for authorship, including approval of the final manuscript, and they should be able to take public responsibility for the work and should have full confidence in the accuracy and integrity of the work of other group authors."
ARTICLE TYPES
ORIGINAL CONTRIBUTIONS:
This category includes original research including both clinical and basic science submissions. The work must be original and neither published, accepted, or submitted for publication elsewhere. Any related work, either SUBMITTED, in press, or published from any of the authors should be clearly cited and referenced.
All clinical trials must be registered in a public trials registry that is acceptable to the International Committee of Medical Journals Editors (ICMJE). Go to (http://www.icmje.org/faq.html). Authors of randomized controlled trials must adhere to the CONSORT guidelines, available at: www.consort-statement.org, and provide both a CONSORT checklist and flow diagram. We require that you choose the MS Word template at www.consort-statement.org for the flow chart and cite/upload it in the manuscript as a figure. In addition, submitted manuscripts must include the unique registration number in the Abstract as evidence of registration.
All authors are expected to abide by accepted ethical standards for human and animal investigation. In studies that involve human subjects or laboratory animals, authors must provide an explicit statement in Materials and Methods that the experimental protocol was approved by the appropriate institutional review committee and meets the guidelines of their responsible governmental agency. In the case of human subjects, informed consent, in addition to institutional review board approval, is required.
The Journal will consider and occasionally publishes ANIMAL STUDIES. However, as our focus is on clinical aspects of colorectal disease, these papers are of low priority and are generally limited to those that provide particular biological insight or have direct and usually near-term therapeutic implications. In studies that involve laboratory animals authors must adhere to the ARRIVE guidelines and provide an ARRIVE checklist. Cite and upload same in the manuscript as a figure. We refer you to the following links:
Article - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043335/
Guidelines with link to Checklist: http://www.nc3rs.org.uk/ARRIVE
Only a limited number of BASIC SCIENCE PAPERS are considered for publication. These are selected at the discretion of the editor(s) based upon novelty, relevance, and the quality of the research.
Original contributions comprising survey data of surgeon practice and attitudes are considered to be of low publication priority and their submission is discouraged. Our Journal does not publish results of surveys.
TECHNICAL NOTES AND VIDEO VIGNETTES (limited to a total of 12 references):
……
更多详情：
https://edmgr.ovid.com/dcr/accounts/ifauth.htm
